255 related articles for article (PubMed ID: 26161475)
1. Entry of Francisella tularensis into Murine B Cells: The Role of B Cell Receptors and Complement Receptors.
Plzakova L; Krocova Z; Kubelkova K; Macela A
PLoS One; 2015; 10(7):e0132571. PubMed ID: 26161475
[TBL] [Abstract][Full Text] [Related]
2. A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu.
Barel M; Hovanessian AG; Meibom K; Briand JP; Dupuis M; Charbit A
BMC Microbiol; 2008 Sep; 8():145. PubMed ID: 18789156
[TBL] [Abstract][Full Text] [Related]
3. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
[TBL] [Abstract][Full Text] [Related]
4. B cell subsets are activated and produce cytokines during early phases of Francisella tularensis LVS infection.
Plzakova L; Kubelkova K; Krocova Z; Zarybnicka L; Sinkorova Z; Macela A
Microb Pathog; 2014 Oct; 75():49-58. PubMed ID: 25200734
[TBL] [Abstract][Full Text] [Related]
5. A method for functional trans-complementation of intracellular Francisella tularensis.
Steele S; Taft-Benz S; Kawula T
PLoS One; 2014; 9(2):e88194. PubMed ID: 24505427
[TBL] [Abstract][Full Text] [Related]
6. Francisella tularensis enters macrophages via a novel process involving pseudopod loops.
Clemens DL; Lee BY; Horwitz MA
Infect Immun; 2005 Sep; 73(9):5892-902. PubMed ID: 16113308
[TBL] [Abstract][Full Text] [Related]
7. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
8. Interaction of B cells with intracellular pathogen Francisella tularensis.
Krocova Z; Härtlova A; Souckova D; Zivna L; Kroca M; Rudolf E; Macela A; Stulik J
Microb Pathog; 2008 Aug; 45(2):79-85. PubMed ID: 18524531
[TBL] [Abstract][Full Text] [Related]
9. Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis.
Geier H; Celli J
Infect Immun; 2011 Jun; 79(6):2204-14. PubMed ID: 21422184
[TBL] [Abstract][Full Text] [Related]
10. Early cellular responses of germ-free and specific-pathogen-free mice to Francisella tularensis infection.
Krocova Z; Plzakova L; Benuchova M; Macela A; Kubelkova K
Microb Pathog; 2018 Oct; 123():314-322. PubMed ID: 30055244
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
Green M; Choules G; Rogers D; Titball RW
Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
Cole LE; Shirey KA; Barry E; Santiago A; Rallabhandi P; Elkins KL; Puche AC; Michalek SM; Vogel SN
Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS.
Chen F; Cui G; Wang S; Nair MKM; He L; Qi X; Han X; Zhang H; Zhang JR; Su J
Emerg Microbes Infect; 2017 Jul; 6(7):e66. PubMed ID: 28745311
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
15. Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo.
Straskova A; Spidlova P; Mou S; Worsham P; Putzova D; Pavkova I; Stulik J
Pathog Dis; 2015 Nov; 73(8):ftv058. PubMed ID: 26253078
[TBL] [Abstract][Full Text] [Related]
16. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
Culkin SJ; Rhinehart-Jones T; Elkins KL
J Immunol; 1997 Apr; 158(7):3277-84. PubMed ID: 9120284
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
Zhang P; Katz J; Michalek SM
Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
[TBL] [Abstract][Full Text] [Related]
19. The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
Rees DG; Hartley MG; Green M; Lukaszewski RA; Griffin KF; Atkins HS; Lyons R; Krieg AM; Titball RW
Microb Pathog; 2013 Oct; 63():16-8. PubMed ID: 23707360
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.
D'Elia R; Jenner DC; Laws TR; Stokes MG; Jackson MC; Essex-Lopresti AE; Atkins HS
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):348-61. PubMed ID: 21569124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
